In 2023, the sold production of ozone therapy, oxygen therapy, aerosol therapy, and respiration apparatus in the UK stood at an undisclosed value. As we step into 2024, with a forecast of 106.35 million euros, the sector anticipates a consistent upward trend through 2028. The consecutive yearly values project relatively stable growth, with nominal percentage increases ranging year-on-year, reflecting the sector's potential resilience and gradual expansion.
The sector is projected to increase by approximately 0.91% annually, as indicated by the compound annual growth rate (CAGR) over the five-year period from 2024 to 2028. Over this duration, the UK market for these medical apparatuses is expected to foster steady development driven by ongoing advancements in healthcare and increasing demand for respiratory health solutions.
Future trends to watch for include technological advancements in medical devices, increased healthcare spending, and the potential impact of regulatory changes within the healthcare sector. Additionally, tracking the development of home healthcare services and telemedicine could provide further insights into market dynamics.
